Repurposed drug combo tested as new hope for tough cancers
NCT ID NCT03889795
Summary
This is an early-stage study testing the safety of a combination of three existing drugs—metformin, digoxin, and simvastatin—in people with advanced pancreatic cancer or other solid tumors that have worsened despite standard treatment. The main goal is to find the highest dose patients can tolerate without severe side effects. Researchers will also check if the treatment shows any signs of slowing the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Toledo, Eleanor N. Dana Cancer Center
Toledo, Ohio, 43614, United States
Conditions
Explore the condition pages connected to this study.